U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07945665) titled 'Diagnostic Performance and Safety of Ragweed Pollen and Dog Dander Skin Prick Test Solutions' on Nov. 05.
Brief Summary: This multicenter, open-label, Phase III interventional study will evaluate the diagnostic performance and safety of ragweed pollen and dog dander skin prick test (SPT) solutions in adults in China with current or previous allergic diseases. Participants will undergo serum allergen-specific immunoglobulin E (sIgE) testing using the Thermo Fisher Scientific ImmunoCAP system. Each enrolled participant will receive one skin prick with ragweed pollen solution (3,500 DU/mL), dog dander solution (19,500 DU/mL), dog dande...